Pharmaceutical Executive, January 2023 Issue (PDF)

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive: January 2023
Volume 43
Issue 01

Click cover to access PDF

Download Issue PDF
Articles in this issue
Key Factors Attributing to a Successful Product Launch
Key Factors Attributing to a Successful Product Launch
Closing the Digital Gap: FDA’s Oversight of Social Media
Closing the Digital Gap: FDA’s Oversight of Social Media
Sales-Rep Compensation: Adding Long-Term Incentives to Mix
Sales-Rep Compensation: Adding Long-Term Incentives to Mix
Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff
Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff
Co-creating New Innovations
Co-creating New Innovations
The Potential Impact of the IRA
The Potential Impact of the IRA
Patient Hubs Continue Growth
Patient Hubs Continue Growth
Social Media’s Complex Climb
Social Media’s Complex Climb
Industry Workforce Seeks Clarity
Industry Workforce Seeks Clarity
Cybersecurity Threats & Pharma
Cybersecurity Threats & Pharma
What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook
What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook
Natalie Bickford, chief people officer, Sanofi
Enabling Authenticity
Biopharma Investment Implications: Looking Back and Forward
Biopharma Investment Implications: Looking Back and Forward
Payer Key Business Factors for Orphan Product Launches
Payer Key Business Factors for Orphan Product Launches
Innovating the Go-to-Market Model in Asia
Innovating the Go-to-Market Model in Asia
Recent Videos
John Arena
John Arena
John Arena
Related Content
FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors

FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors

Don Tracy, Associate Editor
February 28th 2025
Article

FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Lauren D'Angelo

Enhanced Intellectual Property Protection: Q&A with Lauren D’Angelo

Mike Hollan
February 28th 2025
Article

The Alpha Cognition executive discusses recent developments that positively impact the upcoming launch for ZUNVEYL.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Ecopipam Demonstrates Promise in Patients with Tourette Syndrome

Ecopipam Demonstrates Promise in Patients with Tourette Syndrome

Don Tracy, Associate Editor
February 28th 2025
Article

Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor antagonist for patients with Tourette syndrome.

Kristine Ashcraft

Screening for DPD: Q&A with Kristine Ashcraft

Mike Hollan
February 28th 2025
Article

The YouScript CEO discusses new FDA guidance.